Works matching IS 15228517 AND DT 2013 AND VI 15 AND IP 6

Results: 22

Phase I trial of capecitabine rapidly disintegrating tablets and concomitant radiation therapy in children with newly diagnosed brainstem gliomas and high-grade gliomas.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 759, doi. 10.1093/neuonc/nos315

By:

Kilburn, Lindsay B.;
Kocak, Mehmet;
Schaedeli Stark, Franziska;
Meneses-Lorente, Georgina;
Brownstein, Carrie;
Hussain, Sazzad;
Chintagumpala, Murali;
Thompson, Patrick A.;
Gururangan, Sri;
Banerjee, Anuradha;
Paulino, Arnold C.;
Kun, Larry;
Boyett, James M.;
Blaney, Susan M.

Publication type:

Article

Efficacy of protracted temozolomide dosing is limited in MGMT unmethylated GBM xenograft models.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 735, doi. 10.1093/neuonc/not010

By:

Cen, Ling;
Carlson, Brett L.;
Pokorny, Jenny L.;
Mladek, Ann C.;
Grogan, Patrick T.;
Schroeder, Mark A.;
Decker, Paul A.;
Anderson, S. Keith;
Giannini, Caterina;
Wu, Wenting;
Ballman, Karla V.;
Kitange, Gaspar J.;
Sarkaria, Jann N.

Publication type:

Article

Subscription Page.

Published in:: Neuro-Oncology, 2013, v. 15, n. 6, p. NP, doi. 10.1093/neuonc/nos383
Publication type:: Article

Prognostic significance of the aggregative perivascular growth pattern of tumor cells in primary central nervous system diffuse large B-cell lymphoma.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 727, doi. 10.1093/neuonc/not012

By:

He, Miaoxia;
Zuo, Changjing;
Wang, Jianjun;
Liu, Jianmin;
Jiao, Binghua;
Zheng, Jianmin;
Cai, Zailong

Publication type:

Article

Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 718, doi. 10.1093/neuonc/not015

By:

Agarwal, Shipra;
Sharma, Mehar Chand;
Jha, Prerana;
Pathak, Pankaj;
Suri, Vaishali;
Sarkar, Chitra;
Chosdol, Kunzang;
Suri, Ashish;
Kale, Shashank Sharad;
Mahapatra, Ashok Kumar;
Jha, Pankaj

Publication type:

Article

Patterns of care and outcome for patients with glioblastoma diagnosed during 2008–2010 in Spain.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 797, doi. 10.1093/neuonc/not013

By:

Graus, Francesc;
Bruna, Jordi;
Pardo, Javier;
Escudero, Domingo;
Vilas, Dolores;
Barceló, Inés;
Brell, Marta;
Pascual, Carmen;
Crespo, José A.;
Erro, Elena;
García-Romero, Juan C.;
Estela, Jordi;
Martino, Juan;
García-Castaño, Almudena;
Mata, Elena;
Lema, Manuela;
Gelabert, Miguel;
Fuentes, Rafel;
Pérez, Pedro;
Manzano, Arancha

Publication type:

Article

A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 783, doi. 10.1093/neuonc/not021

By:

Cohen, Kenneth J.;
Gibbs, Iris C.;
Fisher, Paul G.;
Hayashi, Robert J.;
Macy, Margaret E.;
Gore, Lia

Publication type:

Article

Contents Page.

Published in:: Neuro-Oncology, 2013, v. 15, n. 6, p. NP, doi. 10.1093/neuonc/nos347
Publication type:: Article

Cover Page.

Published in:: Neuro-Oncology, 2013, v. 15, n. 6, p. NP, doi. 10.1093/neuonc/nos359
Publication type:: Article

Bevacizumab treatment of symptomatic pseudoprogression after boron neutron capture therapy for recurrent malignant gliomas. Report of 2 cases.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 650, doi. 10.1093/neuonc/not020

By:

Miyatake, Shin-Ichi;
Furuse, Motomasa;
Kawabata, Shinji;
Maruyama, Takashi;
Kumabe, Toshihiro;
Kuroiwa, Toshihiko;
Ono, Koji

Publication type:

Article

Society news.

Published in:: Neuro-Oncology, 2013, v. 15, n. 6, p. 806, doi. 10.1093/neuonc/not083
Publication type:: Article

NPV-LDE-225 (Erismodegib) inhibits epithelial mesenchymal transition and self-renewal of glioblastoma initiating cells by regulating miR-21, miR-128, and miR-200.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 691

By:

Fu, Junsheng;
Rodova, Mariana;
Nanta, Rajesh;
Meeker, Daniel;
Van Veldhuizen, Peter J.;
Srivastava, Rakesh K.;
Shankar, Sharmila

Publication type:

Article

Trends in treatment and outcomes of pediatric craniopharyngioma, 1975–2011.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 767, doi. 10.1093/neuonc/not026

By:

Cohen, Michal;
Bartels, Ute;
Branson, Helen;
Kulkarni, Abhaya V.;
Hamilton, Jill

Publication type:

Article

Editorial Board.

Published in:: Neuro-Oncology, 2013, v. 15, n. 6, p. NP, doi. 10.1093/neuonc/nos371
Publication type:: Article

Is knowledge of brain metabolism the key to treating highly glycolytic cancers and metastases?

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 649, doi. 10.1093/neuonc/not041

By:

Mathews, Edward Henry;
Liebenberg, Leon

Publication type:

Article

SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation ...

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 788, doi. 10.1093/neuonc/not019

By:

Calaminus, Gabriele;
Kortmann, Rolf;
Worch, Jennifer;
Nicholson, James C.;
Alapetite, Claire;
Garrè, Maria Luisa;
Patte, Catherine;
Ricardi, Umberto;
Saran, Frank;
Frappaz, Didier

Publication type:

Article

MiR-106a is an independent prognostic marker in patients with glioblastoma.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 707, doi. 10.1093/neuonc/not001

By:

Zhao, Shiguang;
Yang, Guang;
Mu, Yulong;
Han, Dayong;
Shi, Chen;
Chen, Xin;
Deng, Yifan;
Zhang, Daming;
Wang, Lu;
Liu, Yaohua;
Hou, Xu;
Wang, Chunlei;
Wu, Jianing;
Liu, Huailei;
Wang, Ligang;
Zhang, Guang;
Qi, Jiping;
Fang, Xiang;
Shi, Changbin;
Ai, Jing

Publication type:

Article

Adoptive transfer of genetically modified Wilms' tumor 1–specific T cells in a novel malignant skull base meningioma model.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 747, doi. 10.1093/neuonc/not007

By:

Iwami, Kenichiro;
Natsume, Atsushi;
Ohno, Masasuke;
Ikeda, Hiroaki;
Mineno, Junichi;
Nukaya, Ikuei;
Okamoto, Sachiko;
Fujiwara, Hiroshi;
Yasukawa, Masaki;
Shiku, Hiroshi;
Wakabayashi, Toshihiko

Publication type:

Article

1p/19q codeletion and IDH1/2 mutation identified a subtype of anaplastic oligoastrocytomas with prognosis as favorable as anaplastic oligodendrogliomas.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 775, doi. 10.1093/neuonc/not027

By:

Jiang, Haihui;
Ren, Xiaohui;
Cui, Xiangli;
Wang, Junmei;
Jia, Wenqing;
Zhou, Zhiming;
Lin, Song

Publication type:

Article

Which drug or drug delivery system can change clinical practice for brain tumor therapy?

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 656, doi. 10.1093/neuonc/not016

By:

Siegal, Tali

Publication type:

Article

Accumulation of 2-hydroxyglutarate is not a biomarker for malignant progression in IDH-mutated low-grade gliomas.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 682, doi. 10.1093/neuonc/not006

By:

Juratli, Tareq A.;
Peitzsch, Mirko;
Geiger, Kathrin;
Schackert, Gabriele;
Eisenhofer, Graeme;
Krex, Dietmar

Publication type:

Article

Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments.

Published in:

Neuro-Oncology, 2013, v. 15, n. 6, p. 670, doi. 10.1093/neuonc/not003

By:

Merz, Felicitas;
Gaunitz, Frank;
Dehghani, Faramarz;
Renner, Christof;
Meixensberger, Jürgen;
Gutenberg, Angelika;
Giese, Alf;
Schopow, Kosta;
Hellwig, Christian;
Schäfer, Michael;
Bauer, Manfred;
Stöcker, Horst;
Taucher-Scholz, Gisela;
Durante, Marco;
Bechmann, Ingo

Publication type:

Article